| Literature DB >> 33968225 |
Müge Özçelik Korkmaz1, Bilgehan Çelik1, Fatih Turan1, Mehmet Güven1, Ebru Güven2.
Abstract
Introduction There are no definitive parameters to guide the etiology and severity of pediatric antrochoanal polyps. Objective The aim of our study is to compare the values of blood cell distribution parameters in cases of pediatric antrochoanal polyps (ACPs) with those of the control group. These values may be guiding parameters in determining the etiology of ACPs and evaluating the severity of the disease and the risk of recurrence. Methods Blood count values of patients operated for pediatric ACPs were retrospectively analyzed and compared with the data of the control group with the same age and gender distribution. The ACPs group was divided into subgroups in terms of inflammation, severity, and recurrence, and these subgroups were statistically compared as well. Results When the ACP patient group and the control group were compared, there was no statistically significant difference between the two groups. When we compared the patients considering the CT findings, there was a statistically significant difference between the stage III patients and the control group in terms of mean platelet volume (MPV) and platelet-to-lymphocyte ratio (PLR) values ( p < 0.05 in both). Similarly, the MPV and PLR values were significantly higher in the recurrence patient group than in the control group. ( p < 0.05 in both). Conclusion As a result of the data obtained, it can be suggested that inflammatory parameters in pediatric cases of ACPs vary in terms of recurrence and the severity of the disease. Fundação Otorrinolaringologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ).Entities:
Keywords: antrochoanal polyp; blood cell; neutrophil-to-lymphocyte ratio; paranasal sinus tomography; pediatric
Year: 2020 PMID: 33968225 PMCID: PMC8096515 DOI: 10.1055/s-0040-1709194
Source DB: PubMed Journal: Int Arch Otorhinolaryngol ISSN: 1809-4864
Demographic data of patients
| Variables | Study group | Control group |
| ||
|---|---|---|---|---|---|
| n | Mean ± SD (age) | n | Mean ± SD (age) | ||
| Gender | |||||
| Female | 33 | 10.8 ± 2.97 | 28 | 10.28 ± 4.23 |
|
| Male | 30 | 13.23 ± 3.65 | 32 | 12.9 ± 2.41 |
|
| Total | 63 | 12.18 ± 2.97 | 60 | 11.36 ± 2.43 |
|
Abbreviation: SD, standard deviation.
Fig. 1(a–c) Coronal cross-sectional images of patients with stage 1, 2 and 3, respectively, on paranasal sinus tomography.
Comparison of study and control groups in terms of blood cell parameters
| Parameters |
Study group (
|
Control group (
|
|
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| Neutrophil | 4,034 ± 1,175.14 | 3,967.63 ± 1,506,.23 |
|
| Lymphocyte | 2,608.54 ± 893.03 | 2,884.72 ± 954.68 |
|
| Platelet | 2,897.09 ± 45.53 | 2,904.90 ± 54.52 |
|
| Eosinophil | 196.38 ± 156.57 | 222.23 ± 160.6 |
|
| Basophil | 0.09 ± 0.23 | 0.076 ± 0.12 |
|
| RDW | 15.70 ± 1.32 | 15.64 ± 1.02 |
|
| PDW | 17.42 ± 0.87 | 17.26 ± 1.07 |
|
| MPV | 7.38 ± 0.90 | 7.1 ± 0.9 |
|
| NLR | 1.74 ± 0.81 | 1.56 ± 0.89 |
|
| PLR | 126.47 ± 58.95 | 109.41 ± 35.07 |
|
| ELR | 0.07 ± 0.06 | 0.08 ± 0.06 |
|
Abbreviations: ELR, eosinophil-to-lymphocyte ratio; MPV, mean platelet volume; NLR, neutrophil-to-lymphocyte ratio; PDW, platelet distribution width; PLR, platelet-to-lymphocyte ratio; RDW, red blood cell distribution width; SD, standard deviation.
Comparison of blood cell parameters between in recurrence and non-recurrence patients groups
| Parameters |
Recurrent group (
|
Non-recurrent group (
|
|
|---|---|---|---|
| Mean ± SD | Mean ± SD | ||
| Neutrophil | 4,567.64 ± 1,229.26 | 3,778.91 ± 1,093.06 |
|
| Lymphocyte | 2,359.41 ± 785.79 | 2,643,24 ± 955.96 |
|
| Platelet | 290,294.11 ± 376.41 | 280,918.91 ± 489.73 |
|
| Eosinophil | 208,4595 ± 179.15 | 173.0 ± 97.19 |
|
| Basophil | 0.087 ± 0.23 | 0.096 ± 0.12 |
|
| RDW | 15.61 ± 1 | 15.7 ± 1.45 |
|
| PDW | 17.58 ± 1.07 | 17.37 ± 0.77 |
|
| MPV | 7.46 ± 0.83 | 7.34 ± 0.95 |
|
| NLR | 1.96 ± 0.84 | 1.63 ± 0.8 |
|
| PLR | 123.05 ± 71.49 | 106.28 ± 54.1 |
|
| ELR | 0.07 ± 0.06 | 0.08 ± 0.07 |
|
Abbreviations: ELR, eosinophil-to-lymphocyte ratio; MPV, mean platelet volume; NLR, neutrophil-to-lymphocyte ratio; PDW, platelet distribution width; PLR, platelet-to-lymphocyte ratio; RDW, red blood cell distribution width; SD, standard deviation.
Comparison of blood cell parameters in terms of computed tomography findings grading of patients and control group
| Parameters |
Stage I group (
| Stage II | Stage III | Control |
|
|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | ||
| Neutrophil | 4,088.88 ± 1,041.32 | 4,489.18 ± 1,283.61 | 3,983.75 ± 911.48 | 3,967.63 ± 1,506.23 | 0.865 |
| Lymphocyte | 2,494.44 ± 795.17 | 2,733.78 ± 931.54 | 2,213.75 ± 812.56 | 2,871.78 ± 950.91 |
|
| Platelet | 298,555.55 ± 5,269.67 | 290,027.02 ± 4,241.78 | 2,851.25 ± 5,498.44 | 2,895.00 ± 5,429.39 |
|
| Eosinophil | 216.11 ± 165.,11 | 196.89 ± 163.38 | 178 ± 139.38 | 220.89 ± 159.45 |
|
| Basophil | 0.097 ± 0.23 | 0.086 ± 0.12 | 0.089 ± 0.23 | 0.095 ± 0.12 |
|
| RDW | 15.65 ± 0.95 | 15.70 ± 1.43 | 15.56 ± 1.23 | 15.67 ± 1.04 |
|
| PDW | 17.3 ± 0.52 | 17.35 ± 0.82 | 17.97 ± 1.29 | 17.26 ± 1.06 |
|
| MPV | 7.26 ± 0.89 | 7.42 ± 0.93 | 8.31 ± 0.94 | 7.10 ± 0.89 |
|
| NLR | 1.73 ± 0.56 | 1.69 ± 0.85 | 1.94 ± 0.95 | 1.65 ± 0.85 |
|
| PLR | 128.36 ± 44.74 | 122.08 ± 60.89 | 149.86 ± 69.47 | 109.4 ± 34.75 |
|
| ELR | 0.09 ± 0.08 | 0.07 ± 0.06 | 0.07 ± 0.05 | 0.08 ± 0.06 |
|
Abbreviations: ELR, eosinophil-to-lymphocyte ratio; MPV, mean platelet volume; NLR, neutrophil-to-lymphocyte ratio; PDW, platelet distribution width; PLR, platelet-to-lymphocyte ratio; RDW, red blood cell distribution width; SD, standard deviation.